학술논문
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Document Type
Article
Author
Source
In: Frontiers in Cardiovascular Medicine . (Frontiers in Cardiovascular Medicine, 2024, 11)
Subject
Language
English
ISSN
2297055X